A Clinical Study of Hyperthyroidism in Children

Launched by SHENGJING HOSPITAL · Aug 22, 2024

Keywords

ClinConnect Summary

This clinical trial is studying hyperthyroidism in children, a condition where the thyroid gland produces too much hormone, which can affect growth and energy levels. The researchers want to gather information about how hyperthyroidism is diagnosed and treated in kids, as well as how they do over time after treatment. They will look at the effectiveness of antithyroid medications, any side effects, and what factors might predict whether a child will improve or have a recurrence of symptoms once they stop taking the medication.

To be eligible for this study, children must be 14 years old or younger and have been newly diagnosed with hyperthyroidism. Unfortunately, children who have already received treatment for this condition elsewhere or have certain health issues won't be able to participate. If families choose to enroll their child, they can expect to provide some medical history and follow-up information about their child's condition over time, helping researchers learn more about how to better manage hyperthyroidism in young patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age ≤14 years old
• • 2. Initial diagnosis of hyperthyroidism
• Exclusion Criteria:
• • 1. Hyperthyroidism had been treated with medication in other hospitals,
• • 2. History of autoimmune hepatitis, viral hepatitis, hematological diseases, bone marrow or liver transplantation,
• • 3. Patients with incomplete clinical data